Published in Stem Cells Dev on September 14, 2010
Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci U S A (2012) 1.47
Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 1.38
Cell sources for bone regeneration: the good, the bad, and the ugly (but promising). Tissue Eng Part B Rev (2011) 1.26
In vivo directed differentiation of pluripotent stem cells for skeletal regeneration. Proc Natl Acad Sci U S A (2012) 1.14
Cell sources for bone tissue engineering: insights from basic science. Tissue Eng Part B Rev (2011) 1.10
Bone scaffold architecture modulates the development of mineralized bone matrix by human embryonic stem cells. Biomaterials (2012) 1.03
Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model. Cell Rep (2014) 1.01
Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering. Biotechnol Adv (2014) 0.99
Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering. Acta Biomater (2012) 0.98
Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays. Stem Cells Transl Med (2014) 0.97
Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells Dev (2014) 0.92
Concise review: cell-based strategies in bone tissue engineering and regenerative medicine. Stem Cells Transl Med (2013) 0.92
Human embryonic stem cell-derived mesenchymal stem cell seeding on calcium phosphate cement-chitosan-RGD scaffold for bone repair. Tissue Eng Part A (2013) 0.89
In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements. J Tissue Eng Regen Med (2011) 0.89
Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A (2013) 0.89
Modulating the biochemical and biophysical culture environment to enhance osteogenic differentiation and maturation of human pluripotent stem cell-derived mesenchymal progenitors. Stem Cell Res Ther (2013) 0.85
Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium. Acta Biomater (2015) 0.84
There is more to a lipid than just being a fat: sphingolipid-guided differentiation of oligodendroglial lineage from embryonic stem cells. Neurochem Res (2010) 0.84
Enhanced differentiation of human embryonic stem cells on extracellular matrix-containing osteomimetic scaffolds for bone tissue engineering. Tissue Eng Part C Methods (2014) 0.81
Periostin accelerates bone healing mediated by human mesenchymal stem cell-embedded hydroxyapatite/tricalcium phosphate scaffold. PLoS One (2015) 0.80
A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells. Stem Cells Transl Med (2014) 0.79
Ceramide and sphingosine-1-phosphate signaling in embryonic stem cell differentiation. Methods Mol Biol (2012) 0.79
Cultivation of human bone-like tissue from pluripotent stem cell-derived osteogenic progenitors in perfusion bioreactors. Methods Mol Biol (2014) 0.79
Utilization of transgenic models in the evaluation of osteogenic differentiation of embryonic stem cells. Connect Tissue Res (2013) 0.79
Human embryonic stem cells and macroporous calcium phosphate construct for bone regeneration in cranial defects in rats. Acta Biomater (2014) 0.77
Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone. World J Stem Cells (2015) 0.76
Pluripotent Stem Cells and Skeletal Regeneration--Promise and Potential. Curr Osteoporos Rep (2015) 0.75
TMJ Bioengineering: A review. J Oral Biol Craniofac Res (2013) 0.75
Epidermal Growth Factor Tethered to β-Tricalcium Phosphate Bone Scaffolds via a High-Affinity Binding Peptide Enhances Survival of Human Mesenchymal Stem Cells/Multipotent Stromal Cells in an Immune-Competent Parafascial Implantation Assay in Mice. Stem Cells Transl Med (2016) 0.75
Hydrogel fibers encapsulating human stem cells in an injectable calcium phosphate scaffold for bone tissue engineering. Biomed Mater (2016) 0.75
In vivo rescue of the hematopoietic niche by pluripotent stem cell complementation of defective osteoblast compartments. Stem Cells (2017) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell (2007) 10.13
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol (2003) 9.15
Retracted Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science (2004) 7.37
Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells (2001) 6.86
Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol (2000) 6.06
Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res (1997) 3.54
Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation (1997) 3.40
Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet (1987) 3.35
New consensus nomenclature for mammalian keratins. J Cell Biol (2006) 3.27
Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res (2001) 3.06
Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med (2005) 3.04
The role of collagen in bone strength. Osteoporos Int (2005) 2.19
Bone sialoprotein. Crit Rev Oral Biol Med (1999) 2.12
Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells (2006) 2.11
Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci (1991) 2.05
Bone stem cells. J Cell Biochem Suppl (1998) 2.02
Stem cells. Setting standards for human embryonic stem cells. Science (2003) 1.95
Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells (2006) 1.92
Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today (2005) 1.84
Alkaline Phosphatases : Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal (2006) 1.75
Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci U S A (2008) 1.70
In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells (2003) 1.67
The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch (2010) 1.66
Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol (2006) 1.61
Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest (2005) 1.61
In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng (2004) 1.59
A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials (2005) 1.57
Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol (2008) 1.50
Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng (2002) 1.45
Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol (1997) 1.45
Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells (2005) 1.38
Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev (2009) 1.38
Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. J Orthop Res (2006) 1.34
Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A (2007) 1.34
Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells (2007) 1.33
Differentiation of human embryonic stem cells after transplantation in immune-deficient mice. Stem Cells (2005) 1.33
Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials (2009) 1.32
Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med (2001) 1.30
In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. Biomaterials (2007) 1.29
Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds. Biomaterials (2009) 1.28
Effect of ascorbic acid on bone marrow-derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng (2008) 1.28
Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin Cancer Biol (1999) 1.22
In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng (2001) 1.20
Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun (2005) 1.19
Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol (2006) 1.18
Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials (2005) 1.17
The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle (2009) 1.17
Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J Bone Miner Res (2010) 1.14
Tissue engineering of bone: search for a better scaffold. Orthod Craniofac Res (2005) 1.11
In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res (2009) 1.05
Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cells Dev (2007) 1.05
Fluorescence and confocal laser scanning microscopy imaging of elastic fibers in hematoxylin-eosin stained sections. Histochem Cell Biol (1996) 1.05
Molecular mechanisms of alpha-fetoprotein gene expression. Biochemistry (Mosc) (2000) 1.04
Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential. Regen Med (2007) 1.00
Bone sialoprotein and its transcriptional regulatory mechanism. J Periodontal Res (2008) 0.99
Parameters in three-dimensional osteospheroids of telomerized human mesenchymal (stromal) stem cells grown on osteoconductive scaffolds that predict in vivo bone-forming potential. Tissue Eng Part A (2010) 0.98
Cellular methods in cartilage research: primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods (2008) 0.98
Making bone: implant insertion into tissue-engineered bone for maxillary sinus floor augmentation-a preliminary report. J Craniomaxillofac Surg (2003) 0.96
Bone tissue formation from human embryonic stem cells in vivo. Cloning Stem Cells (2008) 0.94
Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med (2004) 0.91
Giemsa as a fluorescent stain for mineralized bone. J Histochem Cytochem (1994) 0.91
Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss. J Endocrinol (1999) 0.91
HA/TCP compounding of a porous CaP biomaterial improves bone formation and scaffold degradation--a long-term histological study. J Biomed Mater Res B Appl Biomater (2005) 0.90
Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis. J Biomed Mater Res A (2004) 0.88
Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications. J Tissue Eng Regen Med (2010) 0.87
Bone formation by transplanted human osteoblasts cultured within collagen sponge with dexamethasone in vitro. J Bone Miner Res (2001) 0.86
Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice. Gene Ther (2002) 0.84
Osteogenic potential of rat spleen stromal cells. Eur J Cell Biol (2003) 0.84
The morphology and selected biological properties of articular cartilage. Ortop Traumatol Rehabil (2001) 0.83
Bone regeneration after enucleation of mandibular cysts: comparing autogenous grafts from tissue-engineered bone and iliac bone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.83
Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofac Surg (2004) 0.81
Effect of vitamin D pretreatment of human mesenchymal stem cells on ectopic bone formation. J Oral Implantol (2006) 0.80
Osteogenic potential of mesenchymal stem cells from bone marrow in situ: role of physicochemical properties of artificial surfaces. Bull Exp Biol Med (2005) 0.80
Biomaterials for bone regeneration. Med Oral Patol Oral Cir Bucal (2010) 0.79
What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell. COPD (2004) 0.77
Improvement in the ability to direct the differentiation of embryonic stem cells. Surg Neurol (2003) 0.76
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell (2007) 10.13
A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med (2011) 8.26
Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet (2004) 7.84
SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A (2003) 6.80
Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell (2008) 6.26
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest (2003) 3.60
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A (2012) 1.93
Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B (2003) 1.78
The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J (2004) 1.74
A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest (2004) 1.71
Wnt/β-catenin signaling is differentially regulated by Gα proteins and contributes to fibrous dysplasia. Proc Natl Acad Sci U S A (2011) 1.62
"Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther (2010) 1.37
In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells (2006) 1.29
Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res (2002) 1.29
Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. J Bone Miner Res (2003) 1.28
Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab (2002) 1.28
Denosumab treatment for fibrous dysplasia. J Bone Miner Res (2012) 1.26
Fibrous dysplasia as a stem cell disease. J Bone Miner Res (2006) 1.25
Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol (2006) 1.18
Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res (2012) 1.17
Ribbing disease: radiographic and biochemical characterization, lack of response to pamidronate. Skeletal Radiol (2002) 1.13
Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone. J Bone Miner Res (2008) 1.12
An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Miner Res (2004) 1.11
Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells (2007) 1.10
Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. Exp Hematol (2007) 1.10
Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors. J Bone Miner Res (2010) 1.08
Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells. J Mol Endocrinol (2010) 1.06
Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. J Clin Endocrinol Metab (2007) 1.05
The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome. J Clin Endocrinol Metab (2008) 1.04
TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J Cell Biochem (2008) 1.03
Bone formation in transplants of human bone marrow stromal cells and hydroxyapatite-tricalcium phosphate: prediction with quantitative CT in mice. Radiology (2004) 1.01
Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A (2008) 0.99
Dental and skeletal stem cells: potential cellular therapeutics for craniofacial regeneration. J Dent Educ (2002) 0.94
Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. J Clin Endocrinol Metab (2006) 0.94
A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome. Nucleic Acids Res (2004) 0.93
Monostotic fibrous dysplasia of the proximal femur and liposclerosing myxofibrous tumor: which one is which? J Bone Miner Res (2006) 0.90
In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements. J Tissue Eng Regen Med (2011) 0.89
Gene expression profile of human bone marrow stromal cells: high-throughput expressed sequence tag sequencing analysis. Genomics (2002) 0.89
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis. Expert Rev Mol Diagn (2010) 0.87
Sensitive and specific method for detecting G protein-coupled receptor mRNAs. Nat Methods (2006) 0.86
The correlation of specific orthopaedic features of polyostotic fibrous dysplasia with functional outcome scores in children. J Bone Joint Surg Am (2006) 0.85
Human maxillary tuberosity and jaw periosteum as sources of osteoprogenitor cells for tissue engineering. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 0.85
GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha. Hum Mol Genet (2007) 0.85
Age-related changes in human bone proteoglycan structure. Impact of osteogenesis imperfecta. J Biol Chem (2002) 0.83
In vitro chromosome aberration tests using human dental pulp cells to detect the carcinogenic potential of chemical agents. Odontology (2006) 0.81
Neuropeptide beckons cells that heal. Nat Med (2009) 0.75
The pathology of fibrous dysplasia and the McCune-Albright syndrome. Pediatr Endocrinol Rev (2007) 0.75
Paolo Bianco (1955-2015). Cell Stem Cell (2015) 0.75